Monitoring lung cancer patients after treatment

Imaging Surveillance After Lung Cancer Treatment

NIH-funded research Veterans Admin Palo Alto Health Care Sys · NIH-11002708

This study looks at how lung cancer patients are checked up on after their treatment, especially using scans like CTs, to see if their follow-up care matches national guidelines and how it affects their chances of staying healthy, with the goal of making sure patients at high risk of cancer coming back get the best care possible.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Admin Palo Alto Health Care Sys NIH-funded
Lab location1 site (Palo Alto, United States)
Project IDNIH-11002708 on NIH RePORTER

What this research studies

This research investigates how well lung cancer patients are monitored after their treatment, focusing on the use of imaging techniques like CT scans. It aims to understand if the follow-up care aligns with national guidelines and how this affects patient outcomes, such as survival rates. By analyzing patterns of care and the effectiveness of different surveillance strategies, the study seeks to improve post-treatment monitoring for patients at high risk of cancer recurrence. The research will also evaluate the impact of newer recommendations based on the stage of cancer and treatment received.

Who could benefit from this research

Good fit: Ideal candidates for this research are lung cancer patients who have recently completed their treatment and are at risk for recurrence.

Not a fit: Patients who are not diagnosed with lung cancer or those who are not undergoing treatment will not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved monitoring strategies that enhance survival rates for lung cancer patients after treatment.

How similar studies have performed: Previous research has shown that structured follow-up care can significantly improve outcomes for cancer patients, suggesting that this approach may also be effective for lung cancer.

Where this research is happening

Palo Alto, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancer therapyburden of disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.